A Telenursing Program to Support Diabetes Self-Management
Development of Telenursing for Diabetes Self-Management Education and Support (DSMES) Among Patients With Type 2 Diabetes Mellitus in Thailand: A Randomized Controlled Trial
1 other identifier
interventional
128
1 country
1
Brief Summary
This randomized controlled trial aims to develop and evaluate a telenursing-based Diabetes Self-Management Education and Support (DSMES) program with uncontrolled type 2 diabetes mellitus in Thailand. The program is designed to improve diabetes self-management through nurse-led education, behavioral support, and regular follow-up delivered via telecommunication technologies. Participants with type 2 diabetes and poor glycemic control will be randomly assigned to either an intervention group receiving a 12-week telenursing DSMES program or a control group receiving usual care. The intervention includes an initial in-person education session followed by structured video call follow-ups provided by nurse. The primary outcome of this study is the feasibility of implementing telenursing for DSMES in Thailand. Secondary outcomes include changes in glycemic control, body mass index, diabetes knowledge, self-care behaviors, coping behaviors, quality of life, healthcare costs, and frequency of acute care use. The findings from this study are expected to provide evidence to support the use of telenursing as an accessible and sustainable approach for diabetes self-management in the Thai healthcare context.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Feb 2026
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 7, 2026
CompletedFirst Posted
Study publicly available on registry
January 26, 2026
CompletedStudy Start
First participant enrolled
February 25, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 27, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
May 27, 2026
March 24, 2026
January 1, 2026
3 months
January 7, 2026
March 20, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Feasibility of telenursing for diabetes self-management education and support (DSMES)
Feasibility outcomes, including participation rate, completion rate, and adherence level, were analyzed using descriptive statistics under the per-protocol (PP) approach, which included only participants who completed all study assessments.
at 12-week follow-up period after enrollment
Secondary Outcomes (9)
Glycated hemoglobin (HbA1c) level
From baseline to 12 weeks after enrollment
Body Mass Index (BMI)
From baseline to 12 weeks after enrollment
Change from baseline in diabetes knowledge score measured by the Diabetes Knowledge Scale (DIAKS)
From baseline to 6 weeks and 12 weeks after enrollment
Self-care behavior
From baseline to 6 weeks and 12 weeks after enrollment
Positive coping behavior
From baseline to 6 weeks and 12 weeks after enrollment
- +4 more secondary outcomes
Study Arms (2)
Telenursing-Based DSMES Program
EXPERIMENTALUsual care
NO INTERVENTIONcontrol group : receive usual care
Interventions
This intervention is a nurse-led, telenursing-based Diabetes Self-Management Education and Support (DSMES) program delivered over a 12-week period. It includes an initial face-to-face diabetes education session followed by scheduled follow-up sessions conducted via video calls. The program focuses on improving diabetes self-management through education, behavioral support, goal setting, problem-solving, and ongoing monitoring tailored to individual patient needs.
Eligibility Criteria
You may qualify if:
- People with T2DM
- Adults (age 20-64) and older adults (65 and above)
- Uncontrolled diabetes, as determined by physician based on the diagnostic criteria of HbA1C \> 7%
- Can read and write
- Own a smartphone
- Having internet connectivity
- Able to receive a video call or with assistance from a caregiver
You may not qualify if:
- Insulin-dependent patients
- Cognitive or mobility impairments , as assessed by the Thai Mental State Examination (TMSE). A TMSE score below 24 was considered indicative of cognitive impairment (The Nurse Association of Thailand, 2025).
- Requiring special nursing care, such as patients with severe diabetic complications or those who are bedridden.
- Previous extensive DSMES exposure
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Nong Pa Khrang Municipal Hospital
Chiang Mai, Thailand
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator, Lecturer
Study Record Dates
First Submitted
January 7, 2026
First Posted
January 26, 2026
Study Start
February 25, 2026
Primary Completion (Estimated)
May 27, 2026
Study Completion (Estimated)
May 27, 2026
Last Updated
March 24, 2026
Record last verified: 2026-01